Blog

Updated on Sep 8, 2025 | Published on Nov 1, 2015 Share

Akadeum and our revolutionary cell sorting technology was featured in Xconomy Detroit. The article focuses on Akadeum’s lean startup method and how it prioritizes customer discovery and feedback. “The two main cell-sorting technologies being used right now, Younger says, involve a ‘wonderful but slow and expensive’ laser-activated method or one that relies on magnets to separate cells from their surroundings. ‘We’re faster than lasers and more gentle than magnets,’ Younger …

Updated on Sep 8, 2025 | Published on Oct 30, 2019 Share

Novel Akadeum microbubble technology can be the answer to improved quality and reduced costs across multiple fields of testing. Akadeum Life Sciences, Inc., an Ann Arbor-based biotechnology company, announced today that it has entered into a collaboration with Agilent Technologies, Inc. to work toward a new method of isolating target molecules for detection. Akadeum aims to disrupt the status quo in isolation technology with their buoyant microbubbles. Notably, Akadeum is …

Updated on Sep 8, 2025 | Published on Dec 17, 2019 Share

Akadeum closes funding to further commercialize its BACS™ Microbubble platform for next-generation sample preparation applications. Akadeum Life Sciences, Inc. announced an initial close of its Series A financing. The company is pursuing additional investment before final close during Q1 2020. These funds will enable Akadeum to focus its commercial adoption on how to solve longstanding problems in sample preparation. The investment includes several Michigan-based angel groups in addition to venture …

Updated on Sep 8, 2025 | Published on Jun 24, 2025 Share

Akadeum Life Sciences, the world leader in advanced cell separation technology, proudly announces a groundbreaking workflow that leverages its proprietary microbubble platform to enable instrument-free, large-scale cell isolation for cell therapy manufacturing. This innovative solution empowers researchers and manufacturers to efficiently isolate target cells directly in processing bags, eliminating the need for complex instrumentation and streamlining the cell therapy workflow to truly enable decentralized and point-of-care manufacturing models, reduce costs …

Updated on Sep 8, 2025 | Published on Mar 28, 2024 Share

We are excited to announce that Akadeum Life Sciences will attend the American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting in Baltimore from May 7-11, 2024. The highlight of the gene and cell therapy calendar, this conference brings together the brightest minds in academia and industry to share the latest scientific research and stay up to date with cutting-edge technologies. As part of our commitment to advancing …

Updated on Sep 8, 2025 | Published on Feb 13, 2024 Share

“Our dedication to thorough research and our commitment to listening to the voice of the customer has resulted in a truly outstanding innovation.” Akadeum Life Sciences was recently featured as a Top 10 BioTech Startup of 2023 by PharmaTech Outlook magazine. In recognition of the award, PharmaTech Outlook published an article highlighting the innovative work happening at Akadeum to reignite the stagnant cell separation market. Akadeum’s microbubble technology overcomes the …

Updated on Sep 8, 2025 | Published on Aug 9, 2023 Share

Brandon McNaughton, CEO and co-founder of Akadeum Life Sciences, was recently highlighted with other influential Michigan-based thought leaders in a Purpose Job’s recent article celebrating Michigan Founders Fund’s 100-member milestone. The Michigan Founders Fund (MFF) recently celebrated reaching over 100 members in its statewide venture network supporting high-growth entrepreneurs. MFF members pledge 1% of equity to a fund for grantmaking focused on underrepresented founders, local talent development, and racial equity. …

Updated on Sep 8, 2025 | Published on Mar 1, 2016 Share

Akadeum CEO Brandon McNaughton recently sat down for a discussion on Sirius XM with Steve Blank. Steve interviewed Brandon as part of Entrepreneurs are Everywhere, and they discussed topics ranging from cell separation with microbubbles to figuring out how to move an idea from an idea to sales. See select quotes from the interview below. Entrepreneurs are Everywhere “The show follows the journeys of founders who share what it takes …

Updated on Sep 8, 2025 | Published on Jan 3, 2024 Share

Brandon McNaughton, CEO of Akadeum Life Sciences Inc., recently shared insights with BioWorld about the company’s Alerion™ Microbubble Cell Separation System, set to transform cell therapy. Akadeum, established in 2014, has developed a unique microbubble-based cell separation technology. The Alerion™ Microbubble Cell Separation System promises to overcome the limitations of existing methods, offering better workflows, scalability, and productivity. The Alerion™ system uses a two-chamber consumable, allowing microbubbles to adhere to …

Updated on Sep 8, 2025 | Published on Mar 2, 2023 Share

The global leader in buoyancy-based cell separation technology recognized for innovation solving workflow challenges in cell and gene therapy research and development ANN ARBOR, Mich., March 02, 2023 — Akadeum Life Sciences Inc., a global leader in buoyancy-based cell separation technology, announces today it has been named in Fast Company’s 10 Most Innovative Biotech Companies of 2023 as part of the prestigious annual list of the World’s Most Innovative Companies. Akadeum’s patented cell …